News
Developing the Long-acting Pipeline: Data analysis, Modelling and accelerating development of Long-acting therapeutics
13 January 2023
Elliot Croft Wins the Roy Mapstone Prize for Developing Novel Long-Acting Microarray Patches at the 27th Ophthalmology and Vision Science Research Prize Meeting
21 December 2022
Off-patent liver disease drug could prevent COVID-19 infection
05 December 2022
Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases
02 December 2022
Taking control of the HIV epidemic – How long-acting injectables can help reach ambitious targets
12 September 2022
Developing a single-injection cure for hepatitis C virus for low- and middle-income countries
29 July 2022
Community engagement – shaping the long-acting technologies pipeline
29 July 2022
Becoming an Expert: Studying how long-acting drug delivery formulations interact with the human immune system
26 July 2022
Delivering innovations to low- and middle-income countries
25 April 2022
Saving lives through long-acting injectable innovation
24 April 2022
News
Developing the Long-acting Pipeline: Data analysis, Modelling and accelerating development of Long-acting therapeutics
13 January 2023
Elliot Croft Wins the Roy Mapstone Prize for Developing Novel Long-Acting Microarray Patches at the 27th Ophthalmology and Vision Science Research Prize Meeting
21 December 2022
Off-patent liver disease drug could prevent COVID-19 infection
05 December 2022
Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases
02 December 2022
Taking control of the HIV epidemic – How long-acting injectables can help reach ambitious targets
12 September 2022
Developing a single-injection cure for hepatitis C virus for low- and middle-income countries
29 July 2022